Actively Recruiting
Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence
Led by Norwegian University of Science and Technology · Updated on 2025-08-22
50
Participants Needed
2
Research Sites
239 weeks
Total Duration
On this page
Sponsors
N
Norwegian University of Science and Technology
Lead Sponsor
H
Helse Nord-Trøndelag HF
Collaborating Sponsor
AI-Summary
What this Trial Is About
To evaluate the usefulness of Deep neural network (DNN) in the evaluation of mediastinal and hilar lymph nodes with Endobronchial ultrasound (EBUS). The study will explore the feasibility of DNN to identify lymph nodes and blood vessel examined with EBUS.
CONDITIONS
Official Title
Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects referred to thoracic department in any of the participating hospitals with undiagnosed enlarged mediastinal and hilar lymph nodes.
- Subjects have to be 218 years of age
You will not qualify if you...
- Pregnancy
- Any patient that the Investigator feels is not appropriate for this study for any reason.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Department of Pulmonology, Levanger Hospital, North Trøndelag Hospital Trust
Levanger, Norway, 7600
Actively Recruiting
2
Department of Thoracic Medicine, St Olavs Hospital
Trondheim, Norway, 7030
Actively Recruiting
Research Team
Ø
Øyvind Ervik, MD
CONTACT
H
Hanne Sorger, MD,PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here